We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+9.46%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$11.9B
AUM Growth
+$1.4B
Cap. Flow
+$748M
Cap. Flow %
6.3%
Top 10 Hldgs %
12.11%
Holding
747
New
202
Increased
220
Reduced
153
Closed
161

Top Buys

Rank Stock Value
1
ASML icon
ASML
ASML
+$134M
2
STM icon
STMicroelectronics
STM
+$103M
3
META icon
Meta Platforms (Facebook)
META
+$89.9M
4
MET icon
MetLife
MET
+$71.9M
5
GILD icon
Gilead Sciences
GILD
+$70.3M

Top Sells

Rank Stock Value
1
TEL icon
TE Connectivity
TEL
+$161M
2
LLY icon
Eli Lilly
LLY
+$153M
3
MRSH
Marsh
MRSH
+$123M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$91.8M
5
EA icon
Electronic Arts
EA
+$79.5M

Sector Composition

Rank Sector Weight
1 Healthcare 43.43%
2 Technology 17.4%
3 Industrials 8.07%
4 Energy 6.4%
5 Financials 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CHE icon
176
Chemed
CHE
$7.07B
$22.6M 0.19%
+37,605
New +$21.3M
ROP icon
177
Roper Technologies
ROP
$38.8B
$22.6M 0.19%
+40,579
New +$22.3M
VNT icon
178
Vontier
VNT
$4.62B
$22.5M 0.19%
667,960
+335,976
+101% +$11.9M
AVDL
179
DELISTED
Avadel Pharmaceuticals
AVDL
$22.1M 0.19%
1,687,313
+182,781
+12% +$2.78M
UDR icon
180
UDR
UDR
$12.4B
$21.9M 0.18%
+483,300
New +$20.7M
EL icon
181
Estee Lauder
EL
$30.6B
$21.8M 0.18%
218,955
+8,628
+4% +$818K
INTA icon
182
Intapp
INTA
$2.57B
$21.7M 0.18%
454,111
+102,088
+29% +$4.12M
CAVA icon
183
CAVA Group
CAVA
$7.51B
$21.5M 0.18%
173,784
-213,913
-55% -$21.7M
ICUI icon
184
ICU Medical
ICUI
$4.32B
$21.3M 0.18%
116,939
-66,369
-36% -$9.83M
BALL icon
185
Ball Corp
BALL
$17.3B
$21.2M 0.18%
312,261
-77,738
-20% -$4.93M
PTGX icon
186
Protagonist Therapeutics
PTGX
$8.51B
$21M 0.18%
466,518
-355,655
-43% -$14.4M
PETQ
187
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$20.9M 0.18%
+680,000
New +$18.4M
ALKS icon
188
Alkermes
ALKS
$8.31B
$20.8M 0.17%
741,680
-329,391
-31% -$8.78M
ELVN icon
189
Enliven Therapeutics
ELVN
$4.15B
$20.6M 0.17%
806,187
+83,683
+12% +$1.94M
ANNX icon
190
Annexon
ANNX
$860M
$20.3M 0.17%
3,430,160
-641,517
-16% -$3.8M
SLNO
191
DELISTED
Soleno Therapeutics
SLNO
$20.3M 0.17%
402,083
+82,878
+26% +$3.97M
MRVL icon
192
Marvell Technology
MRVL
$174B
$20.2M 0.17%
280,483
-298,840
-52% -$20.6M
BSY icon
193
Bentley Systems
BSY
$10.9B
$19.9M 0.17%
+392,336
New +$19.3M
NYT icon
194
New York Times
NYT
$12.2B
$19.9M 0.17%
357,765
-12,181
-3% -$655K
ALGN icon
195
Align Technology
ALGN
$12.4B
$19.7M 0.17%
+77,415
New +$18.3M
NAMS icon
196
NewAmsterdam Pharma
NAMS
$3.21B
$19.3M 0.16%
1,164,677
+681,289
+141% +$11.8M
IDXX icon
197
Idexx Laboratories
IDXX
$44.8B
$19.2M 0.16%
+37,919
New +$18.4M
HES
198
DELISTED
Hess
HES
$19M 0.16%
140,072
-19,999
-12% -$2.78M
TEVA icon
199
Teva Pharmaceuticals
TEVA
$40.2B
$18.9M 0.16%
1,047,553
– –
TCOM icon
200
Trip.com Group
TCOM
$29.8B
$18.7M 0.16%
314,054
-110,209
-26% -$5.1M
6 7
8
9 10

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Woodline Partners's Q3 2024 Portfolio in Review

As of Q3 2024, Woodline Partners held 747 positions worth $11.9B, up 13% from $10.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Woodline Partners deployed $748M of net new capital in Q3 2024, opening 202 new positions and adding to 220 existing holdings. Its largest new stake was ASML: 149,876 shares worth $125M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 42% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Eli Lilly, an estimated $153M trimmed.

  • Woodline Partners's largest Q3 2024 buy was ASML: 149,876 shares worth $125M.
  • Woodline Partners added most to STMicroelectronics in Q3 2024, an estimated $103M increase.
  • Woodline Partners's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $153M.
  • Woodline Partners fully exited TE Connectivity in Q3 2024, selling an estimated $161M.
  • Woodline Partners's ten largest holdings make up 12% of its $11.9B portfolio in Q3 2024.
  • Woodline Partners opened 202 new positions and closed 161 in Q3 2024.
  • Woodline Partners's portfolio value rose 13% quarter-over-quarter to $11.9B.

Based on Woodline Partners's 13F filing for Q3 2024, filed 14 Nov 2024.